Research Roundup: Blood Test for Severe COVID-19 and More
The Pharma Data
JANUARY 21, 2021
Doctors need better tools to evaluate the status of COVID-19 patients as early as possible because many of the treatments—such as monoclonal antibodies—are in short supply, and we know that some patients will get better without intensive treatments,” said co-senior author Andrew E. The research was published in the journal JCI Insight.
52 
Let's personalize your content